Table 3.

Clinical outcomes after initiating sotalol therapy

	≤3 days	≤3 monthsa
N	525	397
Continued sotalol (%)	464 (88.4)	306 (77.1)
Discontinued sotalol (%)	61 (11.6)	91 (22.9)
Reason for discontinuation:
Bradycardia (%)	8 (1.5)	8 (2.0)
Adverse event (%)	10 (1.9)	18 (4.5)
Long QT (%)	19 (3.6)	4 (1.0)
Recurrence of arrhythmia (%)	5 (1.0)	28 (7.1)
Other (%)	19 (3.6)	33 (8.3)

^aPatients who did not discontinue sotalol treatment ≤3 days.

Patients who discontinued sotalol for reasons not related to sotalol were not included (n = 10).